| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |